Pharmaceutical giant AstraZeneca has dismissed claims its experimental Covid-19 vaccine could be fast-tracked in the US amid reports Donald Trump wants to get it approved before the presidential election this autumn. White House insiders claim the US President is considering speeding up regulatory approval for the jab, originally developed by Oxford University scientists. Getting a … Read more
Astrazeneca signs deals to sell coronavirus vaccine to Argentina and Mexico By Matt Oliver For The Daily Mail Published: 21:50 BST, 13 August 2020 | Updated: 21:50 BST, 13 August 2020 Astrazeneca is forging ahead with its potential coronavirus vaccine after signing fresh supply deals in Latin America. Argentina and Mexico are the latest countries … Read more
AstraZeneca and Johnson & Johnson promised to offer their coronavirus vaccines to the US at cost during testimony before a Congressional committee on Tuesday. UK-based Astrazeneca also said that it would ramp up production of its prospective vaccine – created with Oxford University – to ensure that 300 million doses are available to the US … Read more
Drug duo Astrazeneca and Synairgen shares soar as they declare major breakthroughs in battle to develop Covid vaccine and treatment By Matt Oliver For The Daily Mail Published: 21:50 BST, 20 July 2020 | Updated: 22:15 BST, 20 July 2020 Pioneering British drugs companies declared major breakthroughs in the battle against coronavirus yesterday – sending … Read more
AstraZeneca approaches US rival Gilead Sciences to discuss merger By Daily Mail City & Finance Reporter Published: 21:52 BST, 7 June 2020 | Updated: 21:52 BST, 7 June 2020 In what would be the largest healthcare deal on record, AstraZeneca has approached its US rival Gilead Sciences to discuss a merger. AstraZeneca, which is listed … Read more
A British pharmaceutical giant is already manufacturing an unproven coronavirus vaccine as it hopes to dish out hundreds of millions of doses by September. AstraZeneca has started to mass-produce the experimental AZD1222 jab, developed by Oxford University, at factories in India, Oxford, Switzerland and Norway. The Cambridge-based firm expects to have distributed hundreds of millions of … Read more
Pharmaceutical giant AstraZeneca has today agreed to mass-produce a COVID-19 vaccine developed by Oxford University scientists. Human trials of the experimental jab – called ChAdOx1 nCoV-19 – started last week and the first results are expected in mid-June. If proven to protect against the deadly virus, the deal will allow the UK to access to … Read more
Pharmaceutical giant AstraZeneca strikes deal with Oxford University to mass produce experimental COVID-19 vaccine with first results from human trials expected in June The agreement was announced this morning, with the details set to be finalised It will allow for rapid vaccination around the world, if the jab is proven to work And it will … Read more
Drugs giant AstraZeneca in talks with governments to find cure for virus Research agreements could be announced in the coming days A deal would see the company team up with experts on monoclonal antibodies By Jamie Nimmo For The Financial Mail On Sunday Published: 23:05 GMT, 21 March 2020 | Updated: 23:05 GMT, 21 March … Read more